Like Novo Nordisk and George Westinghouse, they strive to make the implementation of the idea as valuable as possible, positioning it as valuable to potential customers
[DOI] [PubMed] [Google Scholar] 112.Widemann B.C., Lu Y., Reinke D., Okuno S.H., Meyer C.F., Cote G.M., Chugh R., Milhem M.M., Hirbe A.C., Kim A., et al
They also demonstrate advantages in areas such as weight loss, improved cardiovascular health, reduced risk of cardiovascular events, and potential cognitive benefits
Effectiveness: A review of four randomized-controlled studies including 3,613 people with obesity but not diabetes found that the average weight loss with semaglutide was just under 12% compared to placebo